Efficacy of N-Acetylcysteine on Liver Function and Metabolic Profiles in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Double-Blind, Randomized Controlled Trial
The trial was registered with the Iranian Registry of Clinical Trials (IRCT20201220049772N1) on February 20, 2021.
Authors
- Abbas Mofidi (ORCID: https://orcid.org/0000-0002-2827-7998)
- Mehdi Kashani (ORCID: https://orcid.org/0000-0001-6868-6481)
- Mohsen Razavizadeh
- Abbas Arj
- Seyyed Mohammad Tabatabaei (ORCID: https://orcid.org/0000-0002-3153-8968)
- Masoud Mortezazadeh (ORCID: https://orcid.org/0000-0003-3585-9379)
- Niyousha Shirsalimi (ORCID: https://orcid.org/0000-0002-3337-942X)
- Mehrdad Sinaeinejad
- Samira Pirzad (ORCID: https://orcid.org/0009-0003-9220-3891)
- Mehdi Karimi (ORCID: https://orcid.org/0009-0006-4388-0214)
Institutions
- Hamedan University of Medical Sciences (IR)
- Iran University of Medical Sciences (IR)
- Kashan University of Medical Sciences (IR)
- Imam Khomeini Hospital (IR)
- Islamic Azad University Medical Branch of Tehran (IR)
- Sina Hospital (IR)
- Tehran University of Medical Sciences (IR)
- Bogomolets National Medical University (UA)
Publication Details
- Journal
- Addiction and Health
- Published
- 2025-11-03
- DOI
- https://doi.org/10.34172/ahj.1667
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00